Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Mona Fiuzat"'
Autor:
Justin A. Ezekowitz, Wendimagegn Alemayehu, Sarah Rathwell, Andrew D. Grant, Mona Fiuzat, David J. Whellan, Tariq Ahmad, Kirkwood Adams, Ileana L. Piña, Lawton S. Cooper, James L. Januzzi, Eric S. Leifer, Daniel Mark, Christopher M. O'Connor, G. Michael Felker
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 77-86 (2022)
Abstract Aims N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) values may be influenced by patient factors beyond the severity of illness, including atrial fibrillation (AF), renal dysfunction, or increased body mass index (BMI). We hypo
Externí odkaz:
https://doaj.org/article/d9ba27970e694527b9600c5e88424965
Autor:
Fouad Chouairi, BS, Justin Pacor, MD, P. Elliott Miller, MD, Michael A. Fuery, MD, Cesar Caraballo, MD, Sounok Sen, MD, Eric S. Leifer, PhD, G. Michael Felker, MD, MHS, Mona Fiuzat, PharmD, Christopher M. O’Connor, MD, James L. Januzzi, MD, Daniel J. Friedman, MD, Nihar R. Desai, MD, MPH, Tariq Ahmad, MD, MPH, James V. Freeman, MD, MPH, MS
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 2, Pp 447-455 (2021)
Objective: To evaluate effects of atrial fibrillation (AF) on cardiac biomarkers and outcomes in a trial population of patients with heart failure (HF) with reduced ejection fraction treated with optimal guideline-directed medical therapy. Methods: W
Externí odkaz:
https://doaj.org/article/48f75c6827664f9e8ed830056cd2819b
Autor:
Melissa A. Daubert, Eric Yow, Huiman X. Barnhart, Ileana L. Piña, Tariq Ahmad, Eric Leifer, Lawton Cooper, Patrice Desvigne‐Nickens, Mona Fiuzat, Kirkwood Adams, Justin Ezekowitz, David J. Whellan, James L. Januzzi, Christopher M. O’Connor, G. Michael Felker
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 10 (2021)
Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is a prognostic biomarker in heart failure (HF) with reduced ejection fraction. However, it is unclear whether there is a sex difference in NT‐proBNP response and whether the
Externí odkaz:
https://doaj.org/article/8202fd89cd6b49ef823af032edb30f12
Autor:
César Caraballo, Nihar R. Desai, Hillary Mulder, Brooke Alhanti, F. Perry Wilson, Mona Fiuzat, G. Michael Felker, Ileana L. Piña, Christopher M. O'Connor, Joanne Lindenfeld, James L. Januzzi, Lawrence S. Cohen, Tariq Ahmad
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 23 (2019)
Background The New York Heart Association (NYHA) classification has served as a fundamental tool for risk stratification of heart failure (HF) and determines clinical trial eligibility and candidacy for drugs and devices. However, its ability to adeq
Externí odkaz:
https://doaj.org/article/d314a098561c4a199cf94dd0ae288c47
Publikováno v:
JACC: Basic to Translational Science, Vol 1, Iss 5, Pp 309-312 (2016)
Externí odkaz:
https://doaj.org/article/c6ec6bb74dc04e499a18ccc7f7415c3d
Autor:
Tariq Ahmad, Nihar Desai, Francis Wilson, Phillip Schulte, Allison Dunning, Daniel Jacoby, Larry Allen, Mona Fiuzat, Joseph Rogers, G Michael Felker, Christopher O'Connor, Chetan B Patel
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0145881 (2016)
BACKGROUND:Classification of acute decompensated heart failure (ADHF) is based on subjective criteria that crudely capture disease heterogeneity. Improved phenotyping of the syndrome may help improve therapeutic strategies. OBJECTIVE:To derive cluste
Externí odkaz:
https://doaj.org/article/4dae9f2dde544d75baedb3c778242e4c
Autor:
Christopher M O'Connor, Mona Fiuzat, Peter E Carson, Inder S Anand, Jonathan F Plehn, Stephen S Gottlieb, Marc A Silver, JoAnn Lindenfeld, Alan B Miller, Michel White, Ryan Walsh, Penny Nelson, Allen Medway, Gordon Davis, Alastair D Robertson, J David Port, James Carr, Guinevere A Murphy, Laura C Lazzeroni, William T Abraham, Stephen B Liggett, Michael R Bristow
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e44324 (2012)
Pharmacogenetics involves complex interactions of gene products affecting pharmacodynamics and pharmacokinetics, but there is little information on the interaction of multiple genetic modifiers of drug response. Bucindolol is a β-blocker/sympatholyt
Externí odkaz:
https://doaj.org/article/cd47e15ce88a411b9af992526484b8c4
Autor:
Ankeet S. Bhatt, Matthew Dimond, Mona Fiuzat, Muthiah Vaduganathan, Orly Vardeny, Punag Divanji, Jan Komtebedde, Martin P. Lefkowitz, Richard Nkulikiyinka, Magnus Petersson, Lothar Roessig, Daniel Schaber, Christopher M. O’Connor, Scott D. Solomon
Publikováno v:
JACC: Heart Failure. 11:254-257
Autor:
Mitchell A. Psotka, William T. Abraham, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Tariq Ahmad, G. Michael Felker, Richard Jacob, Dalane W. Kitzman, Eric S. Leifer, Eldrin F. Lewis, Robert J. Mentz, Richard Nkulikiyinka, Wei Ni, Daniel E. Schaber, Abhinav Sharma, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, Ellis F. Unger, David J. Whellan, Janet Wittes, Stefan D. Anker, Christopher M. O’Connor
Publikováno v:
JACC: Heart Failure. 10:889-901
Autor:
Jawad H. Butt, Pooja Dewan, Ersilia M. DeFilippis, Tor Biering-Sørensen, Kieran F. Docherty, Pardeep S. Jhund, Mikhail N. Kosiborod, Felipe A. Martinez, Olof Bengtsson, Niklas Dyrby Johansen, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Scott D. Solomon, Marc S. Sabatine, Lars Køber, Mona Fiuzat, John J.V. McMurray
Publikováno v:
JACC: Heart Failure. 10:543-555